Department of Neurology, First Affiliated Hospital of Anhui Medical University, Hefei, China.
Collaborative Innovation Centre of Neuropsychiatric Disorder and Mental Health, Hefei, China.
Eur J Neurol. 2020 May;27(5):757-763. doi: 10.1111/ene.14177. Epub 2020 Mar 16.
The aim was to investigate whether probable rapid eye movement sleep behavior disorder (pRBD) is associated with impulse control disorders (ICDs) in drug-naïve patients with Parkinson's disease (PD) and whether baseline pRBD is associated with a higher incidence of ICDs during follow-up.
The Parkinson's Progression Markers Initiative is an international, multicenter, prospective cohort study to identify biomarkers of PD progression. In all, 423 drug-naïve patients with early-stage PD were included in the cross-sectional analysis, and 320 patients who screened negative for any ICDs or related behaviors at baseline were included in the longitudinal analysis.
In the cross-sectional analysis, a significant correlation was found between pRBD and ICDs in drug-naïve patients whilst controlling for potential confounders [odds ratio 2.56, 95% confidence interval (CI) 1.38-4.76, P = 0.003]. In the longitudinal analysis, baseline pRBD was an independent predictor of ICD development over time [hazard ratio (HR) 1.648, 95% CI 1.054-2.576; P = 0.028]. Other significant predictors of ICDs included younger age of onset (HR = 0.973, 95% CI = 0.950-0.997; P = 0.026) and greater State-Trait Anxiety Inventory score (HR = 1.040, 95% CI = 1.020-1.061; P < 0.001).
Our data suggest that identifying baseline pRBD in early-stage PD may help clinicians to choose a better therapeutic strategy so as to prevent or limit neuropsychiatric complications.
本研究旨在探究对于未经药物治疗的帕金森病(PD)患者,是否可能的快动眼睡眠行为障碍(pRBD)与冲动控制障碍(ICD)相关,以及基线时的 pRBD 是否与随访期间 ICD 的更高发生率相关。
帕金森进展标志物倡议(Parkinson's Progression Markers Initiative)是一项国际性、多中心、前瞻性队列研究,旨在确定 PD 进展的生物标志物。共纳入了 423 例处于早期阶段且未经药物治疗的 PD 患者进行横断面分析,纳入了 320 例在基线时筛查出无任何 ICD 或相关行为的患者进行纵向分析。
在横断面分析中,在控制了潜在混杂因素后,pRBD 与未经药物治疗的患者的 ICD 之间存在显著相关性[优势比 2.56,95%置信区间(CI)1.38-4.76,P=0.003]。在纵向分析中,基线时的 pRBD 是 ICD 随时间发展的独立预测因子[风险比(HR)1.648,95%CI 1.054-2.576;P=0.028]。ICD 的其他显著预测因子包括发病年龄较小(HR=0.973,95%CI=0.950-0.997;P=0.026)和状态-特质焦虑量表评分较高(HR=1.040,95%CI=1.020-1.061;P<0.001)。
我们的数据表明,在早期 PD 中识别基线时的 pRBD 可能有助于临床医生选择更好的治疗策略,以预防或限制神经精神并发症。